Effectiveness of IMT/PEP Therapy in Group E COPD and Comparison of GOLD vs STAR Classifications

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

February 3, 2024

Study Completion Date

April 4, 2024

Conditions
COPDInspiratory Muscle Training
Interventions
BEHAVIORAL

Inspiratory Muscle Training / Positive Expiratory Pressure (IMT/PEP) Therapy

IMT/PEP therapy was administered using a dual-function device (BİO Breathe, Korea) designed to provide both inspiratory muscle resistance and positive expiratory pressure. Patients performed the therapy for 15 minutes, twice daily, over a 12-week period, in addition to standard pharmacological treatment. Pressure levels were individually adjusted between 5-40 cmH₂O based on patient capacity.

Trial Locations (1)

25200

Ataturk University, Erzurum

All Listed Sponsors
lead

Bugra Kerget

OTHER

NCT07001462 - Effectiveness of IMT/PEP Therapy in Group E COPD and Comparison of GOLD vs STAR Classifications | Biotech Hunter | Biotech Hunter